重组Ax21蛋白作为抗嗜麦芽窄食单胞菌亚单位疫苗候选的小鼠感染模型研究
本研究将嗜麦芽窄食单胞菌外膜蛋白Ax21在大肠杆菌中克隆并异源表达,以BCG和IFA为佐剂免疫小鼠。ELISA显示免疫鼠产生显著抗原特异性IgG1、IgG2a和总IgG;攻毒后肺、肝、肾、心细菌负荷大幅降低,肝病理征象显著减轻;全菌ELISA和调理吞噬试验证实血清抗体可结合并促进吞噬该菌。
要点
- 重组Ax21蛋白免疫小鼠可诱导抗原特异性IgG1、IgG2a和总IgG抗体应答。
- 免疫鼠攻毒后肺、肝、肾、心细菌负荷显著降低,肝坏死等病理征象明显减轻。
- 免疫血清抗体可结合嗜麦芽窄食单胞菌并促进其被吞噬。
核心结论
- 重组Ax21外膜蛋白对嗜麦芽窄食单胞菌感染在小鼠模型中显示疫苗保护效力,为首次报道。
研究设计与样本
- 研究将嗜麦芽窄食单胞菌Ax21蛋白克隆并在大肠杆菌中异源表达,纯化后以BCG和IFA为佐剂免疫小鼠,随后用嗜麦芽窄食单胞菌攻毒。
主要发现
- ELISA显示免疫小鼠产生显著的抗原特异性IgG1、IgG2a和总IgG水平。
- 免疫小鼠攻毒后肺、肝、肾和心脏的细菌负荷大幅降低。
- 肝组织学检查显示坏死、空泡化、胆管纤维化与坏死、炎症细胞浸润和出血等病理征象显著减少。
- 全菌ELISA和调理吞噬试验分别证实免疫鼠血清抗体能结合嗜麦芽窄食单胞菌并促进其吞噬。
临床怎么用
- 提示Ax21可作为抗嗜麦芽窄食单胞菌亚单位疫苗的候选抗原,但当前证据仅来自小鼠模型。
局限性
- 原文未报告样本量、抗体滴度数值、细菌负荷定量数据及统计学P值。
- 研究仅为小鼠模型,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stenotrophomonas maltophilia is an emerging pathogen that can cause several disease manifestations such as bacteremia, meningitis, respiratory tract infections and others. More seriously, this pathogen has a highly evolving antibiotic resistance profile. Antibiotic misuse is further aggravating the situation by inducing the development of multi- and even pan-resistance. Thus, employing diverse strategies to overcome this increasing antibiotic resistance is of paramount importance. In general, vaccination is one of these strategies that prevents the onset of infection, provides long term protection against infection, and most importantly diminishes the antibiotic consumption, thus, resulting in controlling resistance. Unfortunately, vaccine research concerning S. maltophilia is very scarce in the literature. Ax21 protein is an outer membrane protein implicated in several virulence mechanisms of S. maltophilia such as quorum sensing, biofilm formation, and antibiotic resistance. Our computational analysis of Ax21 revealed its potential immunogenicity. In the current study, Ax21 protein of S. maltophilia was cloned and heterologously expressed in Escherichia coli. Mice were immunized with the purified recombinant antigen using Bacillus Calmette-Guérin(BCG) and incomplete Freund's adjuvant (IFA) as immune-adjuvants. Enzyme-linked immunosorbent assay (ELISA) revealed significant antigen-specific IgG1, IgG2a and total IgG levels in immunized mice which reflected successful immune stimulation. Immunized mice that were challenged with S. maltophilia showed a substantialreduction in bacterial bioburden in lungs, liver, kidneys, and heart. In addition, liver histological examination demonstrated a remarkable decrease in pathological signs such as necrosis, vacuolation, bile duct fibrosis and necrosis, infiltration of inflammatory cells, and hemorrhage. Whole cell ELISA and opsonophagocytic assay confirmed the ability of serum antibodies from immunized mice to bind and facilitate phagocytosis of S. maltophilia, respectively. To our knowledge, this is the first report to demonstrate the vaccine protective efficacy of Ax21 outer membrane protein against S. maltophilia infection.
引用
- Sarhan AT, Bahey-El-Din M, Zaghloul TI, et al. Recombinant Ax21 protein is a promising subunit vaccine candidate against Stenotrophomonas maltophilia in a murine infection model. Vaccine. 2021. PMID: 34187706. doi:10.1016/j.vaccine.2021.06.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。